Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 15/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 4/20 | 0.88 |
| ▸ | HTR1A | P08908 | 3/20 | 0.88 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.88 |
| ▸ | ADRA2B | P18089 | 3/20 | 0.88 |
| ▸ | ADRA2C | P18825 | 3/20 | 0.88 |
| ▸ | HTR2A | P28223 | 3/20 | 0.88 |
| ▸ | HRH1 | P35367 | 3/20 | 0.88 |
| ▸ | DRD3 | P35462 | 3/20 | 0.88 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.88 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.88 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.88 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.88 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.88 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.88 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.88 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.88 |
| ▸ | HTR2B | P41595 | 2/20 | 0.88 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.88 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.88 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20653047 | 0.94 | DRD2 (1.00) | DRD2ADRA1AHTR1AADRA2AADRA2B | |
| Haloperidol SCHEMBL8264 | 0.94 | DRD2 (1.00) | DRD2ADRA1AHTR1AADRA2AADRA2B | |
| Haloperidol SCHEMBL5070670 | 0.94 | DRD2 (1.00) | DRD2ADRA1AHTR1AADRA2AADRA2B | |
| SCHEMBL20254453 | 0.94 | DRD2 (1.00) | DRD2ADRA1AHTR1AADRA2AADRA2B | |
| Moperone SCHEMBL34340 | 0.94 | DRD2 (1.00) | DRD2ADRA1AHTR1AADRA2AADRA2B | |
| Bromperidol SCHEMBL43755 | 0.94 | DRD2 (1.00) | DRD2ADRA1AHTR1AADRA2AADRA2B | |
| SCHEMBL8986042 | 0.94 | DRD2 (1.00) | DRD2ADRA1AHTR1AADRA2AADRA2B | |
| SCHEMBL9052336 | 0.94 | DRD2 (0.91) | DRD2ADRA1AHTR1AADRA2AADRA2B | |
| Haloperidol SCHEMBL15545886 | 0.93 | DRD2 (0.98) | DRD2ADRA1AHTR1AADRA2AADRA2B | |
| Haloperidol SCHEMBL317367 | 0.93 | DRD2 (0.98) | DRD2ADRA1AHTR1AADRA2AADRA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10253035-B2 | Eis inhibitors | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2019-04-09 | — | — | US | disclosed |
| US-20190015400-A1 | Antifungal Compositions | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2019-01-17 | — | — | US | disclosed |
| US-20180162867-A1 | EIS INHIBITORS | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2018-06-14 | — | — | US | disclosed |
| WO-2016186559-A1 | METHOD FOR INVESTIGATING BLOOD-BRAIN BARRIER PROPERTIES AND BRAIN METABOLISM USING INSECT BRAINS | QUIXOLABS AB (SE) | 2016-11-24 | — | — | WO | disclosed |
| WO-2010081036-A2 | FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2010-07-15 | — | — | WO | disclosed |
| WO-1996002250-A1 | HALOPERIDOL ANALOGS AND THE USE THEREOF | ACEA PHARMACEUTICALS INC. (US) | 1996-02-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190015400-A1 | Antifungal Compositions | DPM1, HNMT, ERG28 | DRD2 301/4885ADRA1A 851/4885HTR1A 103/4885 |
| US-20180162867-A1 | EIS INHIBITORS | EP300, ACAT1, ACAT2 | DRD2 4655/4885ADRA1A 2927/4885HTR1A 4703/4885 |
| US-10253035-B2 | Eis inhibitors | EP300, ACAT1, ACAT2 | DRD2 4655/4885ADRA1A 2927/4885HTR1A 4703/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.